Cardiol Therapeutics Inc (CRDL)
1.75
+0.06
(+3.86%)
USD |
NASDAQ |
Apr 19, 16:00
1.75
0.00 (0.00%)
After-Hours: 20:00
Cardiol Therapeutics Price to Book Value: 5.611 for April 19, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 5.402 |
| April 17, 2024 | 5.611 |
| April 16, 2024 | 5.515 |
| April 15, 2024 | 5.739 |
| April 12, 2024 | 5.964 |
| April 11, 2024 | 6.284 |
| April 10, 2024 | 5.996 |
| April 09, 2024 | 6.156 |
| April 08, 2024 | 6.028 |
| April 05, 2024 | 6.092 |
| April 04, 2024 | 6.541 |
| April 03, 2024 | 5.900 |
| April 02, 2024 | 5.803 |
| April 01, 2024 | 6.156 |
| March 28, 2024 | 5.555 |
| March 27, 2024 | 5.525 |
| March 26, 2024 | 5.586 |
| March 25, 2024 | 4.481 |
| March 22, 2024 | 4.542 |
| March 21, 2024 | 4.696 |
| March 20, 2024 | 4.757 |
| March 19, 2024 | 4.665 |
| March 18, 2024 | 4.604 |
| March 15, 2024 | 4.665 |
| March 14, 2024 | 4.358 |
| Date | Value |
|---|---|
| March 13, 2024 | 4.542 |
| March 12, 2024 | 4.481 |
| March 11, 2024 | 4.266 |
| March 08, 2024 | 4.604 |
| March 07, 2024 | 5.003 |
| March 06, 2024 | 4.803 |
| March 05, 2024 | 5.463 |
| March 04, 2024 | 5.402 |
| March 01, 2024 | 6.016 |
| February 29, 2024 | 6.323 |
| February 28, 2024 | 5.678 |
| February 27, 2024 | 5.279 |
| February 26, 2024 | 5.402 |
| February 23, 2024 | 4.972 |
| February 22, 2024 | 4.665 |
| February 21, 2024 | 4.512 |
| February 20, 2024 | 5.126 |
| February 16, 2024 | 4.389 |
| February 15, 2024 | 4.542 |
| February 14, 2024 | 3.192 |
| February 13, 2024 | 3.131 |
| February 12, 2024 | 3.161 |
| February 09, 2024 | 3.253 |
| February 08, 2024 | 3.315 |
| February 07, 2024 | 3.714 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7204
Minimum
Nov 09 2022
12.87
Maximum
Feb 17 2021
4.109
Average
3.914
Median
Nov 15 2019
Price to Book Value Benchmarks
| Aurinia Pharmaceuticals Inc | 1.917 |
| Acasti Pharma Inc | 0.4170 |
| Edesa Biotech Inc | 2.420 |
| Lexaria Bioscience Corp | 4.268 |
| Xenon Pharmaceuticals Inc | 3.241 |
Price to Book Value Related Metrics
| Price | 1.75 |
| Earnings Yield | -18.61% |
| Market Cap | 119.47M |